XML 39 R12.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 1,102,641,000 $ 934,889,000 $ 506,622,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for credit losses (benefit) 83,030,000 (193,464,000) 292,536,000
Goodwill impairment losses 9,000,000 0 0
Amortization of intangibles 3,275,000 9,134,000 6,397,000
Depreciation and amortization of premises and equipment 55,107,000 55,104,000 58,452,000
Net accretion of discounts and amortization of premiums and deferred fees 29,120,000 (21,962,000) (63,300,000)
Interest capitalized on loans subject to the temporary payment moratorium or loss mitigation alternatives (11,521,000) (15,567,000) (95,212,000)
Share-based compensation 16,727,000 17,774,000 8,254,000
Impairment losses on right-of-use and long-lived assets 2,233,000 5,320,000 18,004,000
Fair value adjustments on mortgage servicing rights (166,000) 10,206,000 42,055,000
Fair value adjustment for contingent consideration (9,241,000) 0 0
Adjustments to indemnity reserves on loans sold (919,000) (4,406,000) (390,000)
Earnings from investments under the equity method, net of dividends or distributions (29,522,000) (50,942,000) (27,738,000)
Deferred income tax (benefit) expense (33,129,000) 229,371,000 75,044,000
(Gain) loss on:      
Disposition of premises and equipment and other productive assets (9,453,000) (18,393,000) (11,561,000)
Proceeds from insurance claims 0 0 (366,000)
Sale of debt securities 0 (23,000) (41,000)
Sale of loans, including valuation adjustments on loans held-for-sale and mortgage banking activities 252,000 (21,611,000) (32,449,000)
Sale of equity method investment (8,198,000) 0 0
Disposition of stock as part of the Evertec Transactions (240,412,000) 0 0
Sale of foreclosed assets, including write-downs (33,008,000) (30,098,000) (19,958,000)
Acquisitions of loans held-for-sale (122,363,000) (251,336,000) (227,697,000)
Proceeds from sale of loans held-for-sale 64,542,000 95,100,000 83,456,000
Net originations on loans held-for-sale (202,913,000) (527,585,000) (391,537,000)
Net decrease (increase) in:      
Trading debt securities 353,301,000 741,465,000 493,993,000
Equity securities 54,000 (2,336,000) (8,263,000)
Accrued income receivable (62,932,000) 6,193,000 (35,616,000)
Other assets 76,589,000 25,022,000 114,329,000
Net decrease in:      
Interest payable 6,061,000 (5,395,000) (5,404,000)
Pension and other postretirement benefits obligation (2,893,000) (4,104,000) 5,898,000
Other liabilities (20,724,000) 22,802,000 (106,736,000)
Total adjustments (88,103,000) 70,269,000 172,150,000
Net cash provided by operating activities 1,014,538,000 1,005,158,000 678,772,000
Cash flows from investing activities:      
Net decrease (increase) in money market investments 11,922,703,000 (5,895,789,000) (8,378,577,000)
Purchases of investment securities:      
Available-for-sale (22,232,278,000) (14,672,856,000) (21,033,807,000)
Held-to-maturity (1,879,443,000) 0 0
Equity (48,921,000) (16,196,000) (30,794,000)
Proceeds from calls, paydowns, maturities and redemptions of investment securities:      
Available-for-sale 20,143,921,000 9,602,430,000 18,224,362,000
Held-to-maturity 9,826,000 15,700,000 6,733,000
Proceeds from sale of investment securities:      
Available-for-sale 0 235,992,000 5,103,000
Equity 42,990,000 2,904,000 25,206,000
Net (disbursements) repayments on loans (2,237,084,000) 469,268,000 (875,941,000)
Proceeds from sale of loans 141,314,000 203,179,000 84,385,000
Acquisition of loan portfolios (753,684,000) (348,179,000) (1,138,276,000)
Payments to acquire other intangible 0 (905,000) (83,000)
Payments to acquire businesses, net of cash acquired 0 (155,828,000) 0
Return of capital from equity method investments 681,000 6,362,000 959,000
Payments to acquire equity method investments (1,625,000) (375,000) (1,778,000)
Acquisition of premises and equipment (103,789,000) (72,781,000) (60,073,000)
Proceeds from insurance claims 0 0 366,000
Proceeds from sale of:      
Premises and equipment and other productive assets 10,305,000 21,482,000 26,548,000
Foreclosed assets 107,203,000 86,942,000 77,521,000
Net cash provided by (used in) investing activities 5,350,200,000 (10,518,650,000) (13,068,146,000)
Net (decrease) increase in:      
Deposits (5,770,261,000) 10,138,617,000 13,102,028,000
Assets sold under agreements to repurchase 57,006,000 (29,700,000) (72,076,000)
Other short-term borrowings 290,000,000 75,000,000 0
Payment of notes payable (103,147,000) (237,713,000) (139,920,000)
Principal payments of finance leases (3,346,000) (2,852,000) (3,145,000)
Proceeds from issuance of notes payable 0 0 261,999,000
Proceeds from issuance of common stock 5,837,000 4,674,000 9,093,000
Payments for repurchase of redeemable preferred stock 0 0 (28,017,000)
Dividends paid (161,516,000) (141,466,000) (133,645,000)
Net payments for repurchase of common stock (631,893,000) (350,535,000) (500,479,000)
Payments related to tax witholding for share-based compensation (5,771,000) (5,115,000) (3,693,000)
Net cash (used in) provided by financing activities (6,323,091,000) 9,450,910,000 12,492,145,000
Net increase (decrease) in cash and due from banks, and restricted cash 41,647,000 (62,582,000) 102,771,000
Cash and due from banks and restricted cash at beginning of period 434,512,000 497,094,000 394,323,000
Cash and due from banks and restricted cash at end of period 476,159,000 434,512,000 497,094,000
Other equity method investees      
Proceeds from sale of investment securities:      
Proceeds from sale of equity method investments / Evertec stock sale 8,198,000 0 0
EVERTEC Assets      
Proceeds from sale of investment securities:      
Proceeds from sale of equity method investments / Evertec stock sale $ 219,883,000 $ 0 $ 0